A renowned trademark strategist who exploits IP rights with finesse – Johan Dedeckel
We’re pleased and very proud to announce that Johan Dedeckel got recognized in this year’s World’s Leading Trademark Professionals 1000 by the World Trademark Review, being highly sought after attorneys known for
Calysta, winner of several awards in 2023
Calysta is booming in 2023… Calysta has been recognized by multiple worldwide IP magazines as excellent, a leader, and highly recommended in the field. What a year it has been!
ENTREPRENEUR FOR A DAY AT CALYSTA
How did you experience 1 Day Entrepreneur at Calysta (what was the most remarkable of this experience)? This one day as an entrepreneur has really been an amazing experience
Een slotje op uw intellectuele eigendom
Van merkenrechten over softwarecode tot technische uitvindingen en methodieken om bepaalde productieprocessen te verbeteren… Veel bedrijven zitten op een berg intellectuele eigendom die het absoluut waard is om te beschermen.
Calysta in the Press with our client Colasse
Colasse face aux brevets de Signify, David contre Goliath ? En 2021, Colasse a dû faire face à l’entreprise Signify, leader mondial de l’éclairage, pour violation de brevet. « Ce
Calysta is ranked as LEADING FIRM for Patent Prosecution & EXCELLENT firm for Trademark Prosecution
Each year CALYSTA is getting higher in the rankings 👀😁. The Leaders League rankings are now published and we are pleased to be ranked as LEADING FIRM FOR PATENT PROSECUTION
Calysta is ranked as firm of the year for Patent & Trademark Prosecution. And…we have a Patent star 2022!
Calysta is ranked by IP STARS as firm of the year for Patent and Trademark prosecution. On top of that, the CEO of Calysta, Ludivine Coulon, is ranked as Patent
Calysta is ranked in the Silver grade as best Belgium Patent Prosecution firm
by IAM Patent 1000, https://www.iam-media.com/rankings/patent-1000/profile/firm/calysta
Increase of German annuity fees for patents from 1 July 2022
GERMAN DESK 🔊 Increase of German annuity fees for patents from 1 July 2022 Germany decided to increase the yearly annuity payments for patents from July this year. In Germany,
Covid-19 RNA vaccines – a patent dispute.
On March 17, Alnylam Pharmaceuticals has filed infringement suits against Pfizer and Moderna. The concept of vaccination dates from the French Louis Pasteur (nineteenth century), where inactivated virus are